a biopharma company, two products on the market to control blood sugar for patients with diabetes, and a drug for cholesterol. it has a drug for ulcerative colitis that just got fda approval this week, and it only trades at a slight premium to growth rate. i'm willing to give the stock my blissing, even though it's up very quickly. only for speculation. it can still run ahead of the colitis drug launch in march. this product looks exciting. i liked the stock seven years ago. like it now tweets. david spitsberg cpa. he asks any reason why the only major home builder stock was down? it was up a huge amount. it's been a monster performer. i prefer almost every other home builder to it. pulte home won the stock super bowl. the second tweet from andy. please comment on that. nordic american tanker and what to do after the dividend slash. i don't like nordic american tanker. liked it for a while and the tanker business got really bad. we walked away from it, and i think it's probably with the dividend slash, seems like it's a bottom, i think the worldwide economy doing better. but we said th